Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%

Revvity Inc. (NYSE:RVTY) drew new bullish coverage Monday as William Blair initiated the stock with an Outperform rating, arguing that artificial intelligence could become a net tailwind for the company.

Life Sciences Recovery Could Drive Estimates Higher

Analyst Matt Larew said improving life sciences end markets may not be fully reflected in consensus estimates. The segment accounts for about 52% of Revvity’s revenue.

Pharma and biotech funding is also improving, which could support stronger demand across Revvity’s portfolio.

William Blair expects AI to provide an incremental boost to Revvity’s preclinical business. However, the company’s high-throughput screening, or HTS, business could face some pressure.

The firm’s checks also suggest Revvity’s software business is more resilient than investors may believe.

William Blair said Revvity’s main competitive advantage comes from proprietary data and deeply embedded customer workflows rather than software code that competitors can easily replicate.

AI Narrative Could Become a Tailwind

Revvity shares trade at 25.6 times William Blair’s 2027 earnings-per-share estimate. That compares with the stock’s 10-year average multiple of 21.2 times and represents a slight discount to its peer group.

Larew said recent price action has started to reflect expectations for stronger revenue growth and margin expansion.

However, he sees additional upside as the AI narrative around Revvity’s Signals software business shifts from a perceived competitive risk to a potential growth driver.

The analyst sees more than 20% upside over the next year, supported by positive earnings estimate revisions.

William Blair said Revvity appears to be entering a beat-and-raise cycle as its end markets recover. The firm initiated coverage with an Outperform rating.

Recent Earnings

In August, Revvity reported second-quarter adjusted earnings of $1.41 per share, beating the consensus estimate of $1.22.

Sales came in at $729.67 million, topping the $709.04 million estimate.

“Revvity delivered a strong second quarter, with results above our expectations and encouraging signs of increased demand across our customer base,” said Prahlad Singh, president and CEO of Revvity.

The company raised its fiscal 2026 adjusted earnings guidance to $5.30-$5.40 per share from $5.20-$5.30. The consensus estimate was $5.27 per share.

Revvity also raised its 2026 sales guidance to $2.83 billion-$2.86 billion from $2.81 billion-$2.84 billion. Wall Street expects revenue of $2.858 billion.

RVTY Price Action: Revvity shares were down 2.04% at $154.15 at the time of publication on Tuesday. The stock is approaching its 52-week high of $158.28, according to Benzinga Pro data.

Photo via Shutterstock